What’s new?
On February 21 2025, the European Commission opened a Call for Evidence to evaluate the effectiveness of the Cosmetic Products Regulation (CPR). This initiative aims to assess whether the current regulatory framework is achieving its primary objectives of protecting consumer health and ensuring the smooth functioning of the internal market across the European Union.
The evaluation will focus on five key elements: effectiveness in achieving objectives, efficiency including cost benefits, relevance in the current context, coherence with other EU chemical legislations (such as REACH and CLP Regulations), and the EU “added value” compared to national-level regulatory frameworks.
The European Commission has invited input from all interested stakeholders, including public authorities at national, regional, and local levels, businesses, civil society organisations, and individual citizens.
What now?
The Call for Evidence is open for comments until March 21, 2025. This represents the first phase of a broader evaluation process, with a public consultation expected to follow in May or June 2025, followed by a targeted consultation.
Commission adoption is expected for Second quarter 2026.
